课题基金 / 基金详情

项目摘要

项目成果

JOHN S. LAZO的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Ionizing irradiation induces RNAs in cells which can be targeted prior to irradiation by siRNA to identify novel targets for radioprotector drugs. We have successfully used this strategy to identify a co,mmon drug, Glyburide, as a novel radioprotector. We now propose to apply this strategy to identify radiation mitigator drugs using radiosensitive human cell targets and siRNA screening after irradiation. The 1** Specific Aim will optimize and deploy sentinel cells for detecting RNA targets for new mitigator drugs. The second aim will be to use druggable siRNA libraries and small molecule libraries to identify radiation damage mitigators. The third aim will be to identify targets that interact positively with prioritized drugs to advance radiation mitigation effects.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A PTP4A3 inhibitor for SARS-CoV-2-mediated acute lung injury
  • 批准号:
    10632154
  • 项目类别:
  • 资助金额:
    $0.65万
  • 财政年份:
    2022
  • 负责人:
    JOHN S. LAZO
  • 依托单位:
A PTP4A3 inhibitor for SARS-CoV-2-mediated acute lung injury
  • 批准号:
    10330408
  • 项目类别:
  • 资助金额:
    $25.22万
  • 财政年份:
    2021
  • 负责人:
    JOHN S. LAZO
  • 依托单位:
A PTP4A3 inhibitor for SARS-CoV-2-mediated acute lung injury
  • 批准号:
    10540550
  • 项目类别:
  • 资助金额:
    $5.5万
  • 财政年份:
    2021
  • 负责人:
    JOHN S. LAZO
  • 依托单位:
Developing small molecule PTP4A3 inhibitors for ovarian cancer
  • 批准号:
    9769367
  • 项目类别:
  • 资助金额:
    $28.93万
  • 财政年份:
    2019
  • 负责人:
    JOHN S. LAZO
  • 依托单位:
海外基金